Prof. Avraham Amsterdam revealed that theophylline, a widely used asthma drug, makes ovarian and lung cancer cells more vulnerable to common anticancer medications.
Application
Clinical trials in which theophylline is administered to lung cancer patients in combination with cancer drugs are under way at the Tel Aviv Sourasky Medical Center.